JP2018188381A - 糖尿病予防・治療用医薬組成物、血糖値改善用食品組成物、及び、糖尿病の予防・治療方法 - Google Patents
糖尿病予防・治療用医薬組成物、血糖値改善用食品組成物、及び、糖尿病の予防・治療方法 Download PDFInfo
- Publication number
- JP2018188381A JP2018188381A JP2017090872A JP2017090872A JP2018188381A JP 2018188381 A JP2018188381 A JP 2018188381A JP 2017090872 A JP2017090872 A JP 2017090872A JP 2017090872 A JP2017090872 A JP 2017090872A JP 2018188381 A JP2018188381 A JP 2018188381A
- Authority
- JP
- Japan
- Prior art keywords
- myristic acid
- diabetes
- pharmaceutical composition
- prophylactic
- blood glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 32
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 32
- 235000013305 food Nutrition 0.000 title claims abstract description 29
- 239000008280 blood Substances 0.000 title claims abstract description 25
- 210000004369 blood Anatomy 0.000 title claims abstract description 25
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 22
- 239000008103 glucose Substances 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 230000001225 therapeutic effect Effects 0.000 title abstract description 5
- 230000000069 prophylactic effect Effects 0.000 title abstract 6
- 238000002560 therapeutic procedure Methods 0.000 title abstract 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 claims abstract description 51
- 235000021360 Myristic acid Nutrition 0.000 claims abstract description 34
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000004480 active ingredient Substances 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims description 10
- 150000002148 esters Chemical class 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 241000699670 Mus sp. Species 0.000 description 22
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 235000021314 Palmitic acid Nutrition 0.000 description 8
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 6
- 230000002265 prevention Effects 0.000 description 5
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 102000011107 Diacylglycerol Kinase Human genes 0.000 description 3
- 108010062677 Diacylglycerol Kinase Proteins 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 238000007446 glucose tolerance test Methods 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- -1 myristic acid salt Chemical class 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 235000012045 salad Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 235000021264 seasoned food Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
本実施形態に係る医薬組成物(以下「本医薬組成物」)は、糖尿病予防・治療用医薬組成物であって、ミリスチン酸及びミリスチン酸誘導体の少なくともいずれかを有効成分として含有するものである。
また本医薬組成物は、予防・治療方法に用いることができる。具体的な予防・治療方法は、患者や将来患者となるリスクの高い者に対する投与することが挙げられる。
ミリスチン酸及びミリスチン酸誘導体は、上記医薬組成物としての応用の他、食品組成物としての応用も考えられる。すなわち、本実施形態に係る食品組成物(以下「本食品組成物」という。)は、ミリスチン酸及びミリスチン酸誘導体の少なくともいずれかを有効成分として含むものであって、血糖値を改善することのできる血糖値改善用食品組成物である。
Claims (5)
- ミリスチン酸及びミリスチン酸誘導体の少なくともいずれかを有効成分として含有する糖尿病予防・治療用医薬組成物。
- 前記ミリスチン酸誘導体は、塩及びエステルの少なくともいずれかを含む請求項1記載の糖尿病予防・治療用医薬組成物。
- ミリスチン酸及びミリスチン酸誘導体の少なくともいずれかを有効成分として含む血糖値改善用食品組成物。
- 前記ミリスチン酸誘導体は、塩及びエステルの少なくともいずれかを含む請求項3記載の血糖値改善用食品組成物。
- ミリスチン酸及びミリスチン酸誘導体の少なくともいずれかを有効成分として投与する糖尿病の予防・治療方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017090872A JP7044342B2 (ja) | 2017-04-28 | 2017-04-28 | 糖尿病予防・治療用医薬組成物、血糖値改善用食品組成物、及び、糖尿病の予防・治療方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017090872A JP7044342B2 (ja) | 2017-04-28 | 2017-04-28 | 糖尿病予防・治療用医薬組成物、血糖値改善用食品組成物、及び、糖尿病の予防・治療方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018188381A true JP2018188381A (ja) | 2018-11-29 |
JP7044342B2 JP7044342B2 (ja) | 2022-03-30 |
Family
ID=64479231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017090872A Active JP7044342B2 (ja) | 2017-04-28 | 2017-04-28 | 糖尿病予防・治療用医薬組成物、血糖値改善用食品組成物、及び、糖尿病の予防・治療方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7044342B2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024128051A1 (ja) * | 2022-12-12 | 2024-06-20 | 株式会社J-オイルミルズ | 血管拡張剤、一酸化窒素合成酵素産生促進剤及びその利用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH037539A (ja) * | 1989-03-28 | 1991-01-14 | Procter & Gamble Co:The | ポリオールポリエステル及び低カロリートリグリセリド含有低カロリー脂肪組成物 |
JP2003517051A (ja) * | 1999-12-17 | 2003-05-20 | ザ プロクター アンド ギャンブル カンパニー | 低カロリー脂肪組成物 |
JP2007532096A (ja) * | 2003-11-14 | 2007-11-15 | ノボ ノルディスク アクティーゼルスカブ | アシル化されたインスリンの製造方法 |
JP2012500650A (ja) * | 2008-08-25 | 2012-01-12 | ブランダイス ユニバーシティ | sn−2ミリステート含有食用油 |
JP2013500010A (ja) * | 2009-07-21 | 2013-01-07 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 愛玩動物の栄養系 |
US20130260003A1 (en) * | 2008-08-25 | 2013-10-03 | Brandeis University | Balanced myristate-and laurate-containing edible oil |
JP2014504858A (ja) * | 2010-12-23 | 2014-02-27 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 体重減少および維持のためのペットフード組成物および方法 |
-
2017
- 2017-04-28 JP JP2017090872A patent/JP7044342B2/ja active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH037539A (ja) * | 1989-03-28 | 1991-01-14 | Procter & Gamble Co:The | ポリオールポリエステル及び低カロリートリグリセリド含有低カロリー脂肪組成物 |
JP2003517051A (ja) * | 1999-12-17 | 2003-05-20 | ザ プロクター アンド ギャンブル カンパニー | 低カロリー脂肪組成物 |
JP2007532096A (ja) * | 2003-11-14 | 2007-11-15 | ノボ ノルディスク アクティーゼルスカブ | アシル化されたインスリンの製造方法 |
JP2012500650A (ja) * | 2008-08-25 | 2012-01-12 | ブランダイス ユニバーシティ | sn−2ミリステート含有食用油 |
US20130260003A1 (en) * | 2008-08-25 | 2013-10-03 | Brandeis University | Balanced myristate-and laurate-containing edible oil |
JP2013500010A (ja) * | 2009-07-21 | 2013-01-07 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 愛玩動物の栄養系 |
JP2014504858A (ja) * | 2010-12-23 | 2014-02-27 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 体重減少および維持のためのペットフード組成物および方法 |
Non-Patent Citations (7)
Title |
---|
CELL, vol. 132, JPN6021003989, 2008, pages 375 - 386, ISSN: 0004600470 * |
DIABETES, METABOLIC SYNDROME AND OBESITY: TARGETS AND THERAPY, vol. 5, JPN6021003991, 2012, pages 11 - 19, ISSN: 0004440918 * |
JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 289(38), JPN6021003994, 2014, pages 26607 - 26617, ISSN: 0004440919 * |
LIPIDS, vol. 49, JPN6021003986, 2014, pages 633 - 640, ISSN: 0004600467 * |
LIPIDS, vol. 51, JPN6021003987, 2016, pages 897 - 903, ISSN: 0004600468 * |
PHYSIOLOGICAL REPORTS2015, vol. 3(4), JPN6021003996, 2015, pages 12372 - 1, ISSN: 0004440920 * |
YAKUGAKU ZASSHI, vol. 136(3), JPN6021003988, 2016, pages 461 - 465, ISSN: 0004600469 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024128051A1 (ja) * | 2022-12-12 | 2024-06-20 | 株式会社J-オイルミルズ | 血管拡張剤、一酸化窒素合成酵素産生促進剤及びその利用 |
Also Published As
Publication number | Publication date |
---|---|
JP7044342B2 (ja) | 2022-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2585066T3 (es) | Composiciones para el tratamiento de trastornos neurológicos | |
US20160367529A1 (en) | Debility preventative | |
US20220133782A1 (en) | Methods and compositions for using cinnamaldehyde and zinc for weight management | |
JP2011136907A (ja) | 持久力向上剤 | |
JP4206428B1 (ja) | 認知症を処置するための組成物及びその利用 | |
JP2010018522A (ja) | アディポネクチン産生促進剤 | |
JP6445686B2 (ja) | ジペノサイド75の抗糖尿病効果 | |
JP2016199491A (ja) | 気分状態改善剤 | |
KR20160107420A (ko) | 진세노사이드 f2를 포함하는 비알코올성 간 질환 또는 인슐린 저항성의 예방 또는 치료용 조성물 | |
JP6161438B2 (ja) | 脂肪蓄積抑制及び/又は脂肪蓄積量低減剤 | |
JP2012126683A (ja) | 交感神経活性化用組成物 | |
JP7044342B2 (ja) | 糖尿病予防・治療用医薬組成物、血糖値改善用食品組成物、及び、糖尿病の予防・治療方法 | |
JP2010222284A (ja) | 血中gip上昇抑制剤 | |
JPWO2007040005A1 (ja) | ペルオキシソーム増殖剤応答性受容体PPARα活性化剤、および該活性化剤を含有する特定症状の予防または改善用組成物 | |
WO2007040006A1 (ja) | ペルオキシソーム増殖剤応答性受容体PPARγ活性化剤、および該活性化剤を含有する特定症状の予防または改善用組成物 | |
JP2019006773A (ja) | セレノプロテインpの発現抑制剤及びその利用 | |
JP2023154540A (ja) | 加齢性難聴の予防又は改善のための組成物 | |
JP2007230987A (ja) | 抗肥満剤 | |
US20220023393A1 (en) | Pharmaceutical composition for preventing or treating obesity or sarcopenia, containing if1 as active ingredient | |
US20180078525A1 (en) | Composition for growth promotion, containing coumaric acid as active ingredient | |
JP2017070271A (ja) | 食品またはサプリメント。 | |
JP6912214B2 (ja) | 赤血球機能向上剤 | |
JPH11147828A (ja) | コレステロール及び脂質吸収阻害剤 | |
JP2007039428A (ja) | 体重増加抑制剤 | |
JP2004137287A (ja) | 高血圧症予防・治療剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RD05 | Notification of revocation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7425 Effective date: 20170913 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200304 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210129 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210210 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210401 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20210510 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210528 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20210510 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20210928 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211221 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20211221 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20211221 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20220117 |
|
C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20220118 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220308 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20220310 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7044342 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |